Modern Approach to the Treatment of Acute Respiratory Failure – from nasal cannula to ECMO
Authors:
- Szymon GruszkaSGSzymon Gruszka
- Anna WolffAWAnna Wolff
- Karolina BryłaKBKarolina Bryła
- Marcelina SzewczykMSMarcelina Szewczyk
- Helena Udziela-GilHUHelena Udziela-Gil
- Dominika LewandowskaDLDominika Lewandowska
- Dominika Rosińska-LewandoskaDRDominika Rosińska-Lewandoska
- Julia UfnalJUJulia Ufnal
- Klaudia DrewkoKDKlaudia Drewko
- Michał OlkowskiMOMichał Olkowski
Open Access
- 10 April 2025
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57771
Abstract
Introduction Respiratory failure is a major healthcare issue, significantly threatening patient life. Early diagnosis and appropriate oxygen therapy are critical for improving prognosis. This article aims to summarize and compare current oxygen therapy methods and their clinical indications. Material and Methods Oxygen therapy methods were discussed in the context of acute respiratory failure in the emergency department. The therapies reviewed included conventional oxygen therapy (COT), high-flow nasal oxygen therapy (HFNOT), noninvasive ventilation (NIV), invasive ventilation, and extracorporeal membrane oxygenation (ECMO). Indications were based on the latest guidelines from the European Respiratory Society, American Thoracic Society, and other medical organizations. Results High-flow nasal oxygen therapy (HFNOT) is superior to conventional oxygen therapy in treating acute hypoxemic respiratory failure, reducing the need for therapy escalation. Noninvasive ventilation (NIV) is effective for patients with respiratory acidosis and COPD exacerbations. ECMO is a life-saving option when other treatments fail, but its use is limited to patients with reversible causes of respiratory failure. Conclusions The choice of oxygen therapy depends on the patient's clinical condition. Modern approaches, such as HFNOT and NIV, offer advantages in reducing mortality and the need for invasive ventilation in acute respiratory failure, compared to traditional therapies. ECMO remains effective in severe cases but is reserved for specific indications. Further research is needed to optimize oxygen therapy use, focusing on reducing mortality and complications.Keywords
This publication has 44 references indexed in Scilit:
- Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressurePulmonology, 2022
- A prospective, observational, cohort study of airway management of patients with COVID-19 by specialist tracheal intubation teamsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2020
- German recommendations for critically ill patients with COVID‑19Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2020
- Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guidelineIntensive Care Medicine, 2020
- Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barré SyndromeJournal of Clinical Neuroscience, 2020
- Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow ratesIntensive Care Medicine, 2017
- Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk PatientsJAMA, 2016
- Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress SyndromeJAMA, 2016
- Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancyIntensive Care Medicine, 2010
- Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways diseaseThe Lancet, 1993